As of 2025-03-21, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (23.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.75 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -406.8%.
The range of the Relative Valuation is (25.61) - (23.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 39.8x | 24.1x |
| Forward P/E multiples | 17.9x - 21.6x | 20.2x |
| Fair Price | (25.61) - (23.23) | (23.78) |
| Upside | -430.5% - -399.7% | -406.8% |
| Date | P/E |
| 2025-03-04 | -7.56 |
| 2025-03-03 | -7.55 |
| 2025-02-28 | -7.69 |
| 2025-02-27 | -7.60 |
| 2025-02-26 | -7.79 |
| 2025-02-25 | -7.84 |
| 2025-02-24 | -7.84 |
| 2025-02-21 | -7.70 |
| 2025-02-20 | -7.76 |
| 2025-02-19 | -7.80 |
| 2025-02-18 | -7.70 |
| 2025-02-14 | -7.76 |
| 2025-02-13 | -7.94 |
| 2025-02-12 | -7.03 |
| 2025-02-11 | -7.27 |
| 2025-02-10 | -7.15 |
| 2025-02-07 | -7.30 |
| 2025-02-06 | -7.46 |
| 2025-02-05 | -7.50 |
| 2025-02-04 | -6.87 |
| 2025-02-03 | -7.17 |
| 2025-01-31 | -7.22 |
| 2025-01-30 | -7.32 |
| 2025-01-29 | -7.18 |
| 2025-01-28 | -7.31 |
| 2025-01-27 | -7.17 |
| 2025-01-24 | -7.44 |
| 2025-01-23 | -7.57 |
| 2025-01-22 | -7.46 |
| 2025-01-21 | -6.94 |
| 2025-01-17 | -6.34 |
| 2025-01-16 | -6.45 |
| 2025-01-15 | -6.67 |
| 2025-01-14 | -5.65 |
| 2025-01-13 | -6.02 |
| 2025-01-10 | -6.06 |
| 2025-01-08 | -6.23 |
| 2025-01-07 | -6.61 |
| 2025-01-06 | -6.57 |
| 2025-01-03 | -6.71 |
| 2025-01-02 | -5.77 |
| 2024-12-31 | -5.58 |
| 2024-12-30 | -5.69 |
| 2024-12-27 | -5.86 |
| 2024-12-26 | -6.00 |
| 2024-12-24 | -5.95 |
| 2024-12-23 | -5.89 |
| 2024-12-20 | -5.95 |
| 2024-12-19 | -5.59 |
| 2024-12-18 | -5.56 |